BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/12/2015 5:09:00 PM | Browse: 1141 | Download: 1972
|
Received |
|
2015-05-26 10:20 |
|
Peer-Review Started |
|
2015-05-26 19:22 |
|
To Make the First Decision |
|
2015-07-27 18:38 |
|
Return for Revision |
|
2015-08-01 18:37 |
|
Revised |
|
2015-08-06 15:40 |
|
Second Decision |
|
2015-09-10 08:19 |
|
Accepted by Journal Editor-in-Chief |
|
2015-09-11 10:32 |
|
Accepted by Executive Editor-in-Chief |
|
2015-09-18 14:09 |
|
Articles in Press |
|
2015-09-18 14:09 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2015-10-21 09:51 |
|
Publish the Manuscript Online |
|
2015-11-12 17:09 |
ISSN |
2220-3249 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Virology |
Manuscript Type |
Review |
Article Title |
Hepatitis E virus infection: Epidemiology and treatment implications
|
Manuscript Source |
Invited Manuscript |
All Author List |
Ga Young Lee, Kittiyod Poovorawan, Duangnapa Intharasongkroh, Pattaratida Sa-nguanmoo, Sompong Vongpunsawad, Chintana Chirathaworn and Yong Poovorawan |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Research University Project, Office of Higher Education Commission |
WCU001-HR-57 |
National Research University Project, Office of Higher Education Commission |
WCU007-HR-57 |
National Research University Project, Office of Higher Education Commission |
WCU-58-006-HR |
National Research Council of Thailand |
|
National Science and Technology Development Agency, Chulalongkorn University Centenary Academic Development Project |
CU56-HR01 |
Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University |
RES560530093 |
Outstanding Professor of Thailand Research Fund |
DPG5480002 |
Rachadapisek Sompote Fund of Chulalongkorn University for Postdoctoral Fellowship to Pattaratida Sa-nguanmoo |
|
|
Corresponding Author |
Yong Poovorawan, MD, Professor, Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Rama Ⅳ Rd, Bangkok 10330, Thailand. yong.p@chula.ac.th
|
Key Words |
Treatments; Blood donors; Adverse effects; Vaccination; Pegylated-interferon; Ribavirin; Hepatitis E |
Core Tip |
Hepatitis E virus (HEV) infection affects indivi-duals in both industrialized and developing countries and can cause acute and chronic hepatitis E. HEV genotypes 1 and 2 are primarily found in developing countries due to waterborne transmission, while the zoonotic potential of genotypes 3 and 4 affects mostly industrialized countries. An awareness of HEV transmission through blood donation, especially in the immunocompromised and solid organ transplant patients, merits an effective anti-viral therapy. The current treatment for HEV infection involving ribavirin and pegylated interferon-α therapy has shown limited efficacy. Although not widely used, an HEV vaccine is available for immunization in China.
|
Publish Date |
2015-11-12 17:09 |
Citation |
Lee GY, Poovorawan K, Intharasongkroh D, Sa-nguanmoo P, Vongpunsawad S, Chirathaworn C, Poovorawan Y. Hepatitis E virus infection: Epidemiology and treatment implications. World J Virol 2015; 4(4): 343-355 |
URL |
http://www.wjgnet.com/2220-3249/full/v4/i4/343.htm |
DOI |
http://dx.doi.org/10.5501/wjv.v4.i4.343 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345